These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20050999)

  • 1. Re-exposure to heparin in uremic patients requiring hemodialysis with heparin-induced thrombocytopenia.
    Wanaka K; Matsuo T; Matsuo M; Kaneko C; Miyashita K; Asada R; Matsushima H; Nakajima Y
    J Thromb Haemost; 2010 Mar; 8(3):616-8. PubMed ID: 20050999
    [No Abstract]   [Full Text] [Related]  

  • 2. High ANTI-PF4/Heparin Antibodies Titer and Thromboses Due to Infection 9 Months After Cessation of Heparin in Hemodialyzed Patient With Heparin-Induced Thrombocytopenia.
    Sain M; Burilovic V; Tomicic M; Jelicic I
    Ther Apher Dial; 2018 Oct; 22(5):558-559. PubMed ID: 29856115
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibodies to heparin-platelet factor 4 complex: pathogenesis, epidemiology, and management of heparin-induced thrombocytopenia in hemodialysis.
    Davenport A
    Am J Kidney Dis; 2009 Aug; 54(2):361-74. PubMed ID: 19481318
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparin-induced thrombocytopenia and thrombosis.
    Arepally G; Cines DB
    Clin Rev Allergy Immunol; 1998; 16(3):237-47. PubMed ID: 9773251
    [No Abstract]   [Full Text] [Related]  

  • 5. Heparin-induced thrombocytopenia in hemodialysis patients.
    Yamamoto S; Koide M; Matsuo M; Suzuki S; Ohtaka M; Saika S; Matsuo T
    Am J Kidney Dis; 1996 Jul; 28(1):82-5. PubMed ID: 8712226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and clinical significance of heparin induced antibodies in chronic hemodialysis patients and cardiac surgery patients.
    Shavit L; Bar-Lev M; Lifschitz M; Fink D; Rudensky B; Slotki I
    Int J Artif Organs; 2011 Dec; 34(12):1172-8. PubMed ID: 22198603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis.
    Warkentin TE; Greinacher A; Gruel Y; Aster RH; Chong BH;
    J Thromb Haemost; 2011 Dec; 9(12):2498-500. PubMed ID: 22947414
    [No Abstract]   [Full Text] [Related]  

  • 8. Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic stroke.
    Salem M; Elrefai S; Shrit MA; Warkentin TE
    Thromb Haemost; 2010 Nov; 104(5):1071-2. PubMed ID: 20806120
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of platelet factor 4-heparin complex antibody (HIT antibody) in the pathogenesis of thrombotic episodes in patients on hemodialysis.
    Nakamoto H; Shimada Y; Kanno T; Wanaka K; Matsuo T; Suzuki H
    Hemodial Int; 2005 Oct; 9 Suppl 1():S2-7. PubMed ID: 16223438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-induced thrombocytopenia: diagnosis and management.
    Liebman HA
    Vascular; 2008; 16 Suppl 1():S71-6. PubMed ID: 18544310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of the antiheparin-platelet factor 4 antibody in hemodialysis (HD) patients and its effects upon dialysis access.
    Wallace K; Dasgupta I; Stratton J; Johnston P; Parry R
    Clin Nephrol; 2010 Nov; 74(5):409-10. PubMed ID: 20979952
    [No Abstract]   [Full Text] [Related]  

  • 12. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
    Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA
    Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of antibodies against heparin-platelet factor 4 complex in heparin-induced thrombocytopenia patients in Asian-Indians: relevance to inflammatory markers.
    Kannan M; Ahmad S; Ahmad F; Kale S; Hoppensteadt DA; Fareed J; Saxena R
    Blood Coagul Fibrinolysis; 2005 Oct; 16(7):487-90. PubMed ID: 16175007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The identification and management of heparin-induced thrombocytopenia in the vascular patient.
    LaMuraglia GM; Houbballah R; Laposata M
    J Vasc Surg; 2012 Feb; 55(2):562-70. PubMed ID: 22188737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-heparin-platelet factor 4 antibodies are associated with arterial and venous thrombosis in patients with maintenance haemodialysis.
    Tan Y; Cao L; Lv JC; Yan Y; Zuo L; Wang M; Yu L; Yu F; Zhao MH
    Thromb Haemost; 2009 Dec; 102(6):1282-4. PubMed ID: 19967164
    [No Abstract]   [Full Text] [Related]  

  • 16. Heparin-induced thrombocytopaenia.
    Gounden R; Blockman M
    Cardiovasc J Afr; 2008; 19(6):325-7. PubMed ID: 19104731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of heparin-dependent antibodies and adverse outcomes in hemodialysis patients: a population-based study.
    Pena de la Vega L; Miller RS; Benda MM; Grill DE; Johnson MG; McCarthy JT; McBane RD
    Mayo Clin Proc; 2005 Aug; 80(8):995-1000. PubMed ID: 16092577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-Induced Thrombocytopenia: A Focus on Thrombosis.
    Arepally GM; Padmanabhan A
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):141-152. PubMed ID: 33267665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet count, anti-heparin/platelet factor 4 antibodies and tissue factor pathway inhibitor plasma antigen level in chronic dialysis.
    Luzzatto G; Bertoli M; Cella G; Fabris F; Zaia B; Girolami A
    Thromb Res; 1998 Feb; 89(3):115-22. PubMed ID: 9622039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A little heparin goes a long way: effect of therapeutic levels of unfractionated heparin on the heparin-induced thrombocytopenia-platelet factor 4 ELISA antibody assay.
    Raval JS; Montgomery ND; Rollins-Raval MA
    Blood Coagul Fibrinolysis; 2021 Jun; 32(4):302-303. PubMed ID: 33955863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.